Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

QuantSeq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

ABSTRACT: QuantSeq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

PROVIDER: PRJNA926620 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23194010.fastq.gz	Fastqsanger.gz
	SRR23194011.fastq.gz	Fastqsanger.gz
	SRR23194012.fastq.gz	Fastqsanger.gz
	SRR23194013.fastq.gz	Fastqsanger.gz
	SRR23194014.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

QuantSeq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

Project description:QuantSeq from MCF-7, U2OS, and RPE-1 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE223513 | GEO

CAGE-seq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

Project description:CAGE-seq from MCF-7, U2OS, and RPE-1 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE223512 | GEO

Nutlin-3a induced changes in the transcriptome of parental and RFX7-/- U2OS cells

Project description:RNA-seq from parental and RFX7-/- U2OS cells treated with Nutlin-3a or DMSO control

2023-02-28 | GSE173483 | GEO

Nutlin-3a induced changes in the transcriptome of HCT116 and RPE-1 cells

Project description:RNA-seq from HCT116 and RPE-1 hTERT cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE216720 | GEO

CAGE-seq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

Project description:CAGE-seq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

| PRJNA926621 | ENA

Nutlin-3a-induced changes in the proteome of parental and RFX7 knock-out U2OS cells

Project description:Mass spectrometry-based whole proteome analysis of parental and RFX7 knock-out U2OS cells treated with 10 µM Nutlin-3a or DMSO solvent control. Ten biological replicates were used.

2023-03-11 | PXD024869 | Pride

Protein binding to PDCD4 promoter X-box in Nutlin-3a treated U2OS cells

Project description:Human PDCD4 wild-type (wt) promoter fragments were amplified from U2OS genomic DNA and X-box deletion mutants (mut) were generated using the QuikChange site-directed mutagenesis kit (Agilent Technologies). DNA probes for affinity purification with the same sequences were obtained by PCR using a biotinylated primer for labeling the 3' end (Thermo Fisher Scientific). DNA affinity purification with nuclear extracts from Nutlin-3a treated U2OS cells.

2024-08-08 | PXD020932 | Pride

Expression data from human sarcoma patient samples treated with either vehicle control or Nutlin-3a

Project description:This study has examined the molecular mechanisms underlying sensitivity of sarcomas to Nutlin-3a, a non-genotoxic activator of the p53 pathway. Human patient material was collected immediately following surgical resection, dissected into small pieces and ex planted onto gelatin sponges immersed in media containing either vehicle control or Nutlin-3a (10uM and/or 50uM) for 48 hours. Nutlin-3a represents a novel targeted therapy for the treatment of sarcomas. We have examined expression profiles of genes upregulated in sarcoma patient derived tissues following nutlin-3a treatment ex vivo 16 samples ((Vehicle control and Nutlin-3a (10uM and 50uM) treated samples)) from 6 sarcoma patients

2014-03-10 | E-GEOD-48296 | biostudies-arrayexpress

ANKRA2-regulated transcriptome in U2OS

Project description:Identification of the ANKRA2-regulated transcriptome in Nutlin-3a and DMSO control treated U2OS cells

2022-03-04 | GSE162162 | GEO

RFX7-regulated transcriptome in U2OS

Project description:Identification of the RFX7-regulated transcriptome in Nutlin-3a and DMSO control treated U2OS cells

2021-06-17 | GSE162163 | GEO